Paraluman S Leonin

FDA Investigator Report

Total Inspections: 46

Total 483s Issued: 19

Total Warning Letters Issued: 0

Inspection Details

Longest Inspection: 5 days

Shortest Inspection: 1 days

Average Length of Inspection: 0.4 days

Discover the bigger picture. This is just the tip of the iceberg.

Gain access to comprehensive analysis, detailed reports, AI assistant, and much more.

Schedule a Demo

Recent Inspections

DateCompanyCityCountryFEI Number483
2013-04-22Underwriters LaboratoriesCantonUnited States1216976
2013-03-15Denison Pharmaceuticals, LLCLincolnUnited States1210580
2013-01-17TGA Sciences, Inc.MedfordUnited States3002966869
2012-11-20Vapco IncorporatedLawrenceUnited States1219408
2012-09-20Beth Israel Deaconess Medical Center IRBBostonUnited States1219208
2012-08-02Vertex Pharmaceuticals IncorporatedBostonUnited States1000513211
2012-06-08Momenta Pharmaceuticals, Inc.CambridgeUnited States3005948218
2012-04-18DUSA Pharmaceuticals, Inc.BillericaUnited States3002513708
2012-03-14American Gas Products LLCEverettUnited States3005704952
2011-12-09Cubist Pharmaceuticals, Inc.LexingtonUnited States1000513172

Sign Up to get the complete report.

Download 483s and EIRs for Paraluman S Leonin

Co-Inspectors

NameInspectionsLast Inspection
Kenneth H Williams92013
Felix Maldonado42008
Javier O Vega32011
Luella J Rossi32010
Michele L Obert22009
Valentino Fiorella12009

Active Locations

Year-wise Inspection Count